Adding Bristol-Myers Squibb/AbbVie's Empliciti to Revlimid, developed by BMS' recently acquired Celgene unit, does not improve survival in untreated multiple myeloma, a study has shown. BMS announced ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Finding your personal style can be a fun and ...

It might be hard to imagine, but if you had never tasted a peanut butter and jelly sandwich before, you might think that particular combo sounds crazy. And yet in reality it’s an absolute classic. I ...

The royal family could be mortally wounded by Andrew’s scandal if they’re not careful, says a royal author.